CPHI India 2025 - Olefin Metathesis as Key to Innovative API Processes

Apeiron Synthesis will attend CPHI India 2025, one of the key events for the pharmaceutical and fine chemicals industry in South Asia. Taking place from November 25–27 at the India Expo Centre in Greater Noida (Delhi NCR), the event will bring together API manufacturers, CDMOs, and technology providers from around the world. We’ll be represented by Aleksandra Walczak, Sales Representative and Nils Drabik, Research Scientist - ready to talk about how olefin metathesis catalysts can support innovation, sustainability, and efficiency in pharmaceutical synthesis.

Our Presence at CPHI India

CPHI & PMEC India is the largest pharma-focused trade show in the region, gathering more than 50,000 attendees and 2,000 exhibitors from over 120 countries. It is a hub for technical exchange, partnership building, and sourcing of cutting-edge solutions. For Apeiron Synthesis, it’s a valuable opportunity to engage with companies in the Indian pharmaceutical sector looking to modernize their synthetic strategies with reliable, scalable technologies like olefin metathesis.

Olefin Metathesis in the Indian Pharma Landscape

India is a global leader in API production, generic drug manufacturing, and contract research and manufacturing. As the demand for more complex, sustainable, and cost-efficient processes grows, olefin metathesis offers a strategic advantage. Our ruthenium-based catalysts are used to streamline multi-step syntheses, increase selectivity, and reduce waste — enabling better atom economy and faster process development.

What We bring to the Table

At Apeiron Synthesis, we support our partners from early-stage R&D to commercial scale-up. Our catalysts have been successfully applied in the synthesis of pharmaceutical intermediates, fine chemicals, and specialty compounds. At CPHI India, we want to explore how our metathesis solutions can be adapted to your specific needs - whether you're rethinking a synthetic route, addressing sustainability goals, or exploring new technology platforms.

Let's connect in Dehli NCR

Are you attending CPHI India 2025? Let’s talk. Our representative will be available throughout the event to discuss the potential of olefin metathesis in your projects, from lab to production scale. Reach out to schedule a meeting, we look forward to productive conversations and new collaborations.

📍 Event: CPhI India 2025
🗓️ Date: November 25–27, 2025
📌 Location: New Delhi, India
🔗 CPHI India 2025 in Delhi: The heart of South Asia’s pharma

About Apeiron Synthesis

Apeiron Synthesis is an innovative chemical company based in Poland (EU), specializing in advanced olefin metathesis catalysts. With state-of-the-art laboratories and a team of experienced scientists, we support R&D and production activities around the world.